Skip to main content
Andrew Ip, MD, Oncology, Hackensack, NJ

AndrewC.IpMDMSc

Oncology • Hackensack, NJ

Hematologic Oncology

Division of Lymphoma Outcomes and Value Based Care Division

Join to view full profile

Dr. Ip is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ip's full profile

Already have an account?

  • Office

    92 2nd Street
    Hackensack, NJ 07601

Summary

  • As chief of the Outcomes and Value Care Division and a member of the Division of Lymphoma at John Theurer Cancer Center, I lead the center’s outcomes and values care research effort. My focus is on reviewing data about cancer patients across the Hackensack Meridian Health system to understand how to achieve the best patient outcomes as well as value from their outcome, whether it be cost or improved quality of life.

    • Andrew Ip, M.D., MS, considers the whole patient when creating a treatment plan

    Dr. Andrew Ip, chief of the Outcomes and Value Care Division and a member of the Division of Lymphoma at John Theurer Cancer Center considers the whole pati...

Education & Training

  • Emory University, Laney Graduate School
    Emory University, Laney Graduate SchoolMSc, Clinical research, 2017 - 2019
  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 2012 - 2015
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2012

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • GA State Medical License
    GA State Medical License 2014 - 2020
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational Study  
    Noa Biran, Andrew Ip, Ronaldo Collo Go, The Lancet Rheumatology

Authored Content

  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020
  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020

Press Mentions

  • New Model Can Help Clinicians to Predict 40-Day Mortality Risk in Hospitalized COVID-19 Patients
    New Model Can Help Clinicians to Predict 40-Day Mortality Risk in Hospitalized COVID-19 PatientsAugust 2nd, 2021
  • Diagnosis, Clinical Characteristics, and Outcomes of COVID-19 Patients from a Large Healthcare System in Northern New Jersey
    Diagnosis, Clinical Characteristics, and Outcomes of COVID-19 Patients from a Large Healthcare System in Northern New JerseyFebruary 23rd, 2021
  • Yale Doctor Slams Fauci for His Dismissal of Hydroxychloroquine in COVID Treatment
    Yale Doctor Slams Fauci for His Dismissal of Hydroxychloroquine in COVID TreatmentFebruary 1st, 2021
  • Join now to see all

Dr. Andrew Ip, Dr. Andrew Ip, MD, Dr. A Ip, Dr. Andrew C. Ip